Media Contact

Mark Sheridan, media@aclum.org

In a major victory for public health, the U.S. District Court for the District of Massachusetts today struck down the National Institutes of Health’s (NIH) directives that led to the cancellation of research grants based on sweeping, politically driven criteria. The court ruled that NIH’s actions targeting research involving disfavored topics and populations were unlawful, arbitrary and capricious, and therefore void. The court reversed the grant terminations at issue in the case, stating that the government must immediately make the funds available.

“Today’s decision is a crucial step in protecting public health and safeguarding critical research that helps us understand, prevent, and treat life-threatening diseases,” said plaintiff Dr. Brittany Charlton, associate professor at Harvard Chan School of Public Health. “Scientific research must be guided by evidence, not political agendas, and this ruling rightly restores important research projects that should never have been disrupted.”

“We are grateful that this ruling upholds the rigorous scientific process that the NIH has had in place for decades,” said Dr. Heidi Moseson, senior research scientist at plaintiff Ibis Reproductive Health. “Our research is about improving the accuracy of data collected in reproductive health research—work that is designed to improve the quality of care for all Americans. We should have been doing this work all along, without disruption. With this ruling, our team is one step closer to returning to the work we have already invested so much time and thought into. We will do everything we can to make up for lost time and ensure that the American public has the data we promised to deliver as soon as possible.”

“The ideologically motivated directives to terminate grants alleged to constitute DEI, ‘gender ideology,’ or other forbidden topics were, in fact, arbitrary and capricious, and have now been ruled unlawful,” said Center for Science in the Public Interest President Dr. Peter G. Lurie, one of the plaintiffs in the case. “Judge Young’s ruling thankfully starts researchers getting back to work delivering progress on cancer, diabetes, Alzheimer’s, HIV, and other health challenges facing our diverse population.”

In February, the NIH began a reckless purge of federal grants, halting application processes midstream, and stripping funding opportunities from its website. Hundreds of research projects — many of which have been underway for years, representing thousands of hours of work and billions of dollars in investment — were abruptly cancelled without a reasonable explanation.

On April 2, the American Civil Liberties Union, the ACLU of Massachusetts, Protect Democracy, and the Center for Science in the Public Interest filed a lawsuit challenging the abrupt cancellations on behalf of individual researchers, along with the American Public Health Association (APHA); the International Union, United Automobile, Aerospace and Agricultural Implement Workers of America (UAW); and Ibis Reproductive Health. Also, joining as co-counsel is Emery Celli Brinckerhoff Abady Ward & Maazel LLP.

“Today’s ruling confirms that science must be guided by evidence, not ideology. By blocking NIH’s unlawful directive, the court has protected the integrity of scientific research and ensured that critical studies, especially those focused on underserved and marginalized communities, can continue without political interference,” said Olga Akselrod, senior counsel in the Racial Justice Program at the ACLU. “This decision safeguards not only the researchers affected, but also the millions of people who stand to benefit from their work.”

“The court’s ruling is a critical check on the dangerous politicization of science,” said Kenneth Parreno, counsel at Protect Democracy. “By purging research funding based on ideology rather than evidence, the government didn’t just break the law; it sought to dictate what science is allowed to study and who gets to benefit. That’s not just an attack on researchers — it’s an attack on democracy itself. Today’s decision affirms that public institutions must serve the public interest, not political agendas.”

Related Content


Court Case
Apr 24, 2025
Placeholder image
  • Racial Justice

APHA v. NIH

In April 2025, researchers, along with American Public Health Association (APHA), the International Union, United Automobile, Aerospace and Agricultural Implement Workers of America (UAW), and Ibis Reproductive Health, filed a lawsuit challenging the abrupt cancellation of research grants by the National Institutes of Health (NIH), the world’s largest public funder of biomedical research. The grants were cancelled after NIH staff were directed to eliminate research on disfavored topics and populations without clear guidance or justification – jeopardizing critical medical discoveries that drive advancements in diagnosing, preventing, and treating life-threatening diseases. In February, the NIH began a reckless purge of federal grants, halting application processes midstream, and stripping funding opportunities from its website. Hundreds of research projects — many of which had been underway for years, representing thousands of hours of work and billions of dollars in investment — were abruptly cancelled without a scientifically valid explanation. NIH attempted to justify the first wave of its sweeping grant cancellations by vaguely citing connections to “gender identity” or “diversity, equity, and inclusion” (DEI), without defining these terms or explaining how they apply to the terminated research. As a result, critical studies addressing urgent health disparities — designed to develop prioritized strategies for populations at the highest risk of disease — were indiscriminately wiped out. This eradication of research expanded to include research on “vaccine hesitancy,” “COVID,” and any research being conducted or involving labs located in South Africa and China. This unprecedented purge marks a sharp departure from the NIH’s longstanding approach, in which funding decisions have been guided by congressional mandates, regulatory requirements, and scientific expertise. NIH grants are among the most competitive and rigorously vetted research funding opportunities in the world, undergoing multiple layers of expert review. Most applications submitted are rejected, and until the time of filing, terminations had been exceedingly rare. Training grants, some of which are designed to facilitate the entry of researchers from historically underrepresented groups into the biomedical field as mandated by Congress, were also canceled, jeopardizing opportunities for the best and the brightest of the next generation of scientists, particularly harming racial and ethnic minorities, women, people from economically disadvantaged backgrounds, and those from rural communities. The researchers, along with APHA, which has 23,000 public health professional members, UAW, a union of 120,000 workers including graduate students, postdocs, researchers, and faculty in higher education, and Ibis Reproductive Health, a global research organization, are represented by the American Civil Liberties Union, the ACLU of Massachusetts, Protect Democracy, and the Center for Science in the Public Interest. The complaint was filed in the U.S. District Court for the District of Massachusetts against the NIH, NIH Director Jay Bhattacharya, the Department of Health and Human Services (HHS), and HHS Secretary Robert F. Kennedy, Jr. The lawsuit claims the agency violated the Administrative Procedure Act (APA) by acting arbitrarily and without justification, failing to provide scientific reasoning or follow proper procedures. NIH also exceeded its legal authority by disregarding congressional mandates to fund health disparities research and address the underrepresentation of certain groups in the medical field, and by failing to comply with grant termination regulations. Additionally, the lawsuit argues that NIH’s actions violate the Fifth Amendment’s due process protections by canceling grants based on vague and undefined criteria. The lawsuit seeks to restore funding to researchers whose grants were unlawfully terminated and to prevent the NIH from continuing to cut awards in this arbitrary and unlawful manner.